首页> 外文期刊>American Journal of Internal Medicine >Aplastic Anemia in Egypt: Current Situation and Future Prospective
【24h】

Aplastic Anemia in Egypt: Current Situation and Future Prospective

机译:埃及再生障碍性贫血的现状和未来展望

获取原文
           

摘要

Aplastic anemia (AA) is a hypoproliferative anemia that led to a significant morbidity and mortality. Recently, dramatic improvement in prognosis of AA was achieved; this was in part due to advances in immunosuppressive therapy and HSCT. Nevertheless, AA is still one of the most challenging hematological disorders that could face a hematologist. This study was conducted at Assiut University Hospital (AUH), Assiut, Egypt to evaluate current situation and future prospective of AA. 63 patients with AA were prospectively enrolled in the study; they were admitted at the Hematology unit, AUH in the period ~(1stJan)2011 to ~(Feb)2012, a 38 patients with iron deficiency anemia (IDA) were included for comparison. Patients' demographic and clinical data were collected through medical history and clinical examination. Both direct and indirect health care costs of anemia were assessed Direct parameters included doctors' and hospital fees, costs of laboratory investigations, medication fees and costs of HSCT or any procedure. Indirect costs included travelling expenses and earning losses. Social burden of anemia was estimated by anemia related morbidity and mortality. Data were analyzed with SPSSV.17, results showed that AA affected young age group with mean age 30.89±13.39 years, without sex predilection, acquired AA was more common than idiopathic (55.6% vs. 44.4%), however mortality was higher in idiopathic AA (46.2%). Causes of aplasia were exposure to chemicals, drugs and hepatitis in order. Only 63.5% of AA were admitted once and 47.6% in general ward, the mean hospital days for patients with AA was 17.73±11.10, compared to 8.32±6.69 in IDA, P=0.000, also higher socio-economic burden of AA was found compared with IDA. These results denoted that management of AA is still ineffective, and that there is a definite need for a strict plan to prevent incidence of AA, particularly in developing countries where effective management of AA is too expensive and relatively unavailable.
机译:再生障碍性贫血(AA)是一种增殖性贫血,可导致明显的发病率和死亡率。最近,AA的预后得到了显着改善。这部分是由于免疫抑制疗法和HSCT的进步。然而,AA仍然是血液学家可能面临的最具挑战性的血液学疾病之一。这项研究是在埃及Assiut的Assiut大学医院(AUH)进行的,旨在评估AA的现状和未来前景。前瞻性纳入了63名AA患者;他们于2011年1月1日至2012年2月在AUH血液科收治,将38例缺铁性贫血(IDA)患者纳入比较。通过病史和临床检查收集患者的人口统计和临床数据。评估了贫血的直接和间接卫生保健费用。直接参数包括医生和医院的费用,实验室检查的费用,药物费用和HSCT的费用或任何程序。间接费用包括差旅费和收入损失。贫血的社会负担通过与贫血相关的发病率和死亡率来估算。用SPSSV.17分析数据,结果显示,AA患病的平均年龄为30.89±13.39岁,没有性别偏爱的年轻年龄段,获得性AA的发病率高于特发性(55.6%vs. 44.4%),但特发性病死率更高AA(46.2%)。发育不全的原因是依次接触化学药品,药物和肝炎。一次仅接受AA的63.5%和普通病房的47.6%,AA患者的平均住院天数为17.73±11.10,而IDA为8.32±6.69,P = 0.000,还发现AA的社会经济负担更高与IDA相比。这些结果表明,AA的管理仍然无效,并且绝对需要制定严格的计划来预防AA的发生,特别是在对AA进行有效管理的费用太高且相对缺乏的发展中国家。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号